Aims: Remote ischemic conditionings, such as pre-and per-conditioning, are known to provide cardioprotection in animal models of ischemia. However, little is known about the neuroprotection effect of postconditioning after cerebral ischemia. In this study, we aim to evaluate the motor function rescuing effect of remote limb ischemic postconditioning (RIPostC) in a rat model of acute cerebral stroke. 
| INTRODUCTION
Stroke is a leading cause of death and disability worldwide. Patients surviving stroke still suffer devastating sensory and motor deficits including lack of coordination and partial paralysis. One of the major pathological outcomes of ischemic stroke is cerebral infarction, which causes great damage to ischemic brain regions, particularly to local neurons. Rescuing of the impaired locomotor function and reduction in the cerebral infarction are two main aims for the establishment and optimization of an effective poststroke therapy.
The concept of remote ischemic conditioning was first raised in 1993, in which a protection of the myocardium from ischemia/ reperfusion injury by a short period of coronary artery occlusion was observed. 1 In general, remote ischemic conditioning represents an experimental intervention which is designed to improve local ischemia through an induction of a distal sub-lethal ischemic insult. Remote ischemic pre-and per-conditionings stand for a distal ischemic insult before and during the local ischemia, respectively, both of which have been proved to be highly effective against ischemia in animal models. [2] [3] [4] [5] [6] Besides, the ischemic preconditioning has been shown highly valuable in clinical application for the prevention of recurrent stroke. 7 However, due to the unpredictability and acuteness of cerebral ischemia, the onset and progression of it could not be efficiently prevented by the neuroprotection effect of pre-conditioning and perconditioning. 8 In contrast, remote ischemic postconditioning mainly represents a distal intervention after the acute onset of local ischemia, making it a good candidate for poststroke rehabilitation. Accumulating evidence suggests that ischemic postconditioning in various distal regions might result in considerable protections in heart, liver, lung, kidney, and brain regions of animal models such as rat, rabbit, and pig. 3, [9] [10] [11] [12] [13] In cerebral ischemia, reduced infarct size, 10 rescued neuronal apoptosis, 13 and ameliorated functional outcomes 14 were commonly observed after remote postconditioning. However, the potential therapeutic application of remote postconditioning is still inconclusive.
Tissue kallikrein (TK; kallidinogenase) is a serine protease specifically acting in the release of the potent vasoactive peptides bradykinin and Lys-bradykinin. 15 The biological effects of kinins are mediated by B1 and B2 transmembrane receptors. 16 In ischemic stroke, TK has shown protection effect through multiple pathways such as inhibition of apoptosis, 17 inhibition of inflammation, promotion of angiogenesis, and neurogenesis. 18 In clinical, intravenous injection of exogenous TK such as human urinary kallidinogenase has been used as a treatment for acute ischemic stroke. However, few studies have focused on endogenous TK and its therapeutic effects on acute ischemic stroke. Notably, endogenous bradykinin stimulation has been implicated as one of several potential mechanisms underlying remote ischemic conditioning, 19 leading us to consider the possibility of endogenous TK as a critical mediator linking remote ischemic postconditioning and its potential application in stroke treatment.
To test the effectiveness and efficiency of remote limb ischemic postconditioning (RIPostC) in poststroke neuro-rehabilitation, daily short-term hind limb ischemia was performed for maximum 21 days with rat models of cerebral ischemia. To clarify the potential roles of TK mentioned above, TK antagonist HOE-140 was injected after RIPostC. Locomotor function, infarct sizes, structure, and neuronal damage of the ischemic areas were then examined.
| MATERIALS AND METHODS

| Experimental design
Four experimental groups were designed, each group contains 10 rats:
sham-operated, MCAO, RIPostC, and RIPostC+HOE140 injection.
RIPostC were performed 2 days after MCAO and HOE140 injection was performed 30 minutes after RIPostC. For detailed illustration, see Figure 1A .
| Rat model of cerebral stroke
A cerebral ischemic rat model 20 to 80%. After a 1.5-hour occlusion, the filament was withdrawn and reperfusion was established. After recovering from anesthesia, the neurologic deficits were measured with a five-point scale. Rats with scores of 1-3 were considered successful models and included in the study and the rats with a score of 0 or 4 were excluded from the study. Rats in the sham-operated group underwent the MCAO procedures without insertion of the filament and occlusion of the middle cerebral artery.
| Procedure of RIPostC
We hypothesize that RIPostC might help alleviate the brain damage and rescue the motor dysfunction after cerebral ischemia. RIPostC was performed as previously described. 21 Briefly, 2 days after MCAO, rats in the RIPostC and HOE-140 groups underwent remote limb conditioning through tight hind limb restriction with thin elastics for 10 min followed by 10 min of reperfusion, and the conditioning was repeated three times one after another daily for 21 consecutive days.
Limb ischemia was confirmed by the pale color and the underskin temperature decrease of the limb (>3°C).
| Administration of HOE-140
The selective bradykinin B2 receptor antagonist HOE-140 was chosen to inhibit the potential effect of kallikrein due to its high specificity, long duration of action, and good tolerability. 22 HOE-140 (100 μg/ kg) dissolved in 0.9% NaCl was intraperitoneally injected in the rats 30 min after RIPostC as previously described. 
| Foot fault test
The foot-fault test assessed placement dysfunction of affected limb.
A horizontal ladder with 34 rods (2-cm interval between adjacent rods) was used as previously described. 24 All animals were trained on this system before the first test. If the forelimb of the affected side fell off or slipped through the rod, this was counted as one fault
footstep. The percentage of foot faults of the right paw out of total steps was calculated. The higher score represents a worse functional outcome. The test was repeated three times for each rat by a rater blinded to the group division and was performed at 48 hours, 7 days, and 21 days after surgery. Functional test was performed by an investigator adequately trained in functional measurements and blinded to the experimental groups.
| Balance beam test
The balance beam walking test was used to evaluate the ability of rats to maintain balance while walking along an elevated beam, thus reflecting their gross motor function and balance ability. The apparatus consisted of a 1.5-m beam with a flat surface of 25 mm width resting 55 cm above the table top on two poles. A box was placed at the end of the beam as the finish point. Before the first test, rats were trained to walk on the beam from one end to the other. The test was repeated three times for each rat by a rater blinded to the group division. The test was performed before, and at 48 hours, 7 days, and 21 days after surgery. A 5-point scale was adopted in the test as follows: 0, the rat was able to balance and walk on the beam using its forelimbs symmetrically; 1, the rat was able to balance and walk on the beam using its unaffected limb preferentially;
Effect of RIPostC on locomotor function recovery. A, illustration of experimental design. B, foot fault test measuring the fault footsteps proportions of four experimental groups at three time points, the higher proportion indicating severer dysfunction of the limb affected. C, balance beam test measuring the locomotor capability of the four experimental groups, the higher score indicating a worse locomotor outcome. Data are expressed as mean ± SD, n = 10/ group. # P < 0.05 vs Sham, *P < 0.05 vs MCAO, 2, the rat was able to balance and walk on the beam mostly relying on the unaffected limb; 3, the rat was not able to balance on the beam once moved; 4, the rat fell off the beam immediately. The average scores were calculated for statistical analysis. The higher score represented a worse functional outcome.
| Measurement of TK levels
Two micromole blood was extracted through external jugular vein, followed by 2500 r/min centrifugation for 10 minutes at 4°C. TK levels were measured using commercial enzyme-linked immunosorbent assay (ELISA) kit, according to manufacturer's guidelines (Rat kallikrein 1 ELISA Kit; CUSABIO BIOTECH CO., LTD, China; CSB-EL012446RA).
All samples were tested in triplicates. Concentrations were calculated from a standard curve and expressed in nanogram per milliliter. The threshold for detection was 0.23 ng/mL. 
| Western blotting analysis
| Magnetic resonance imaging (MRI) scanning
| Histopathological examination
Hematoxylin-eosin (HE) staining and Nissl's staining were employed to observe the pathological change and the morphological features of injured neurons in the cerebral cortex. 21 days after surgery, rats were sacrificed, and the brains were fixed by transcardial perfusion with saline solution, followed by perfusion and immersion in 4% paraformaldehyde. Brains were then dehydrated in a graded series of alcohols and embedded in paraffin. A series of 4-μm-thick sections were cut from the block. Finally, the sections were stained with HE and Nissl's reagents. The slices were observed and photographed with an Olympus BX53 microscope (Tokyo, Japan).
| Immunofluorescence analysis
Immunofluorescent staining of MAP2 (Santa Cruz) for brain tissue was performed on fixed frozen ultra thin sections as previously described. 25 Two areas in each section were chosen at random and photographed by an investigator blinded to the experimental groups. 
| Statistical analysis
All experimental data were analyzed using SPSS20.0 software. Multigroup comparisons of the means were carried out by one-way analysis of variance (ANOVA) followed by Fisher's least square difference post hoc test. For behavioral tests, four experimental groups were compared with each other, and the animal number of each group is 10.
t-test was applied when only two groups were compared. P < 0.05 was considered as statistically significant. Data are presented as mean ± standard deviation (SD).
| RESULTS
| RIPostC results in functional recovery of cerebral ischemic rats
RIPostC was performed daily for 48 hours, 7 and 21 days, respectively. The rats undergoing no MCAO were used as sham-operated group. Two functional tests, including a foot fault test and a balance beam test, were performed after each time point to assess the motor impairment of limb functioning of the rats (experimental design illustrated in Figure 1A ). As shown in Figure 1B 
| Tissue kallirein level in blood is increased after RIPostC
To give insight into the role of kallikrein-kinin system in RIPostC, an ELISA assay was performed with differential blood samples har- 
| RIPostC reduces cerebral infarction volume and attenuates neuronal cell death after cerebral ischemic injury
To look into the pathological outcomes of RIPostC, multiple imaging analyses were applied to assess the cerebral infarct volume and neu- Figure 4B, left) . The abolished by additional HOE-140 (7.03 ± 3.25%; Figure 4C ). These results strongly suggested a neuronal rescuing effect of RIPostC. Taken together, our results indicated that RIPostC therapy could rescue the pathological outcomes of ischemic stroke, suggesting the importance of kallikrein-kinin system in RIPostC process.
| RIPostC increases microvessel density in ischemic area
Angiogenesis is often observed after ischemia and believed to be involved in damage recovery. Microvessel density was evaluated in the ischemic area 21 days after MCAO injury by lectin immunohistochemistry. MCAO caused severe reduction in lectin + microvessels compared with sham-operated group ( Figure 5A) . Notably, the quantity of lectin + microvessels was significantly increased after RIPostC treatment, together with the enhanced microvessel size ( Figure 5B ).
By contrast, HOE-140 co-treatment resulted in lower microvessel density and size, to the similar level of MCAO group ( Figure 5A and B).
| DISCUSSION
RIPostC is a new postconditioning procedure with great potential for neuroprotection following ischemic insult. In this study, we investigated the application and outcome of RIPostC in a rat stroke model as a rehabilitation therapy for acute stroke. Rescued motor function, reduced infarct volume, improved neuronal survival of infarct region, and increased vascular density were observed after daily RIPostC treatment for more than 7 days. We further identified increased endogenous TK levels in blood and ischemic brain tissue, suggesting that enhanced TK signaling pathway might at least partially underlie the observed RIPostC effect. This proposed mechanism was evidenced by the fact that the treatment of TK antagonist HOE-140 partially reversed all of the improvements resulted from long-term RIPostC mentioned above. To our knowledge, our findings have not been reported in any other studies previously.
The purpose of using MCAO rodent model is to replicate the onset and progress of acute cerebral stroke in human. MCAOinduced neurological deficits such as motor uncoordination and asymmetry serve as good scales to assess the recovery efficacy of RIPostC for the future optimization and application of this rehabilitation therapy on stroke patients. The foot fault test is a sensitive indicator for detecting functional impairment of both forelimbs and hindlimbs after cerebral ischemia in rodents, while the balance beam test is a more specific assessment for hindlimb placing deficits.
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In our study, both tests showed significant difference between RIPostC and nonconditioning groups, confirming the reliability and validity of RIPostC on overall motor recovery. Furthermore, the balance beam test is also a good assessment to show motor learning, as its experimental procedure requires pretraining until the animal can successfully walk across the beam without turning around or making faults. 28 Although we did not distinguish motor learning from motor recovery in this work, the consistency of foot fault test result might suggest that the motor recovery effect is the most striking, if not all, functional outcomes of RIPostC for the poststroke therapy. Tests regarding other neurological deficits such as sensory capacities and dexterity should be performed in the future to explore other potential benefits of RIPostC. Repeated short ischemic stimuli was shown to reduce critical ischemic injury by promoting angiogenesis and increasing cerebral blood flow (CBF). 13 We found that the density of lectin+ microvessels was significantly increased after RIPostC therapy. Despite the low possibility that microvessels were less eliminated by RIPostC, it might more likely suggest that RIPostC promoted capillary regeneration and improved collateral circulation. It is also likely that the effectiveness of TK from remote region was agonized by the increased microvessels and CBF.
To date, most studies regarding RIPostC are observational, with its underlying mechanisms to be elucidated. A number of key molecules and signaling pathways have been connected to preconditioning in the nervous system, such as delta opioid receptor, GABA receptor, nitric oxide, adenosine, growth factors, mitochondrial, and nuclear survival proteins. We propose here a necessary role of TK in RIPostC-induced functional and pathological outcomes. TK is known as an important mediator of functional recovery following brain injury. It cleaves low molecular weight kininogen to produce bradykinin, which is subsequently bound to the kinin B2 receptor to elicit an array of biological effects. 15, 29 The kinin B2 receptor is constitutively expressed with a wide tissue distribution, but can be blocked by the B2 receptor antagonist icatibant (HOE-140). No potential off-target effects were observed due to the high potency, good tolerability, and appropriate dose of HOE-140 we used in our work.
Neuroprotective effects were observed upon local injection of the human TK gene into rat brain immediately after cerebral I/R injury. A double-blinded clinical trial showed TK has an effective treatment for patients with acute brain infarction when infused within 48 hours. 30 The protector mechanism was related with an inhibition of apoptosis, inflammation, 31 hypertrophy, and fibrosis, as well as an enhancement of neovascularization. 32 It has been clearly established that TK has pro-angiogenic activity. 33 Exogenous TK is a promising regimen in the treatment of ischemic stroke in humans. However, the use of exogenous TK in the clinic is limited, due to its commercial unavailability and inconvenient intravenous administration. Intriguingly, we observed here a significant increase in endogenous TK levels and capillary density after RIPostC and verify it as the underlying mechanism of observed RIPostC outcomes. Our study suggests that an up-regulation of endogenous expression of TK by RIPostC might compensate those usage disadvantages of exogenous TK.
| CONCLUSIONS
Our results highlight the RIPostC as a potential poststroke therapy to rescue the disability and reduce pathological indices in ischemic areas through the up-regulation of endogenous TK from remote conditioning regions. We propose that RIPostC might serve as feasible, inexpensive, clinically relevant, and safe therapy for the rehabilitation of cerebral stroke. 
